Tianjin Zhongxin Pharmaceutical Group Corp Ltd - Asset Resilience Ratio

Latest as of September 2025: 5.92%

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has an Asset Resilience Ratio of 5.92% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tianjin Zhongxin Pharmaceutical Group Co (600329) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥685.28 Million

≈ $100.28 Million USD Cash + Short-term Investments

Total Assets

CN¥11.59 Billion

≈ $1.70 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 600329 total assets.

Liquid Assets Composition Over Time

This chart breaks down Tianjin Zhongxin Pharmaceutical Group Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 600329 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥685.28 Million	5.92%
Total Liquid Assets	CN¥685.28 Million	5.92%

Asset Resilience Insights

Limited Liquidity: Tianjin Zhongxin Pharmaceutical Group Corp Ltd maintains only 5.92% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Industry Peers by Asset Resilience Ratio

Compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	Drug Manufacturers - Specialty & Generic	2.79%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Harbin Pharmaceutical Group Co Ltd SHG:600664	Drug Manufacturers - Specialty & Generic	0.97%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	9.29%	CN¥1.00 Billion ≈ $146.34 Million	CN¥10.77 Billion ≈ $1.58 Billion	+9.09pp
2023-12-31	0.20%	CN¥20.31 Million ≈ $2.97 Million	CN¥10.23 Billion ≈ $1.50 Billion	-0.36pp
2019-12-31	0.55%	CN¥43.52 Million ≈ $6.37 Million	CN¥7.84 Billion ≈ $1.15 Billion	-0.20pp
2018-12-31	0.75%	CN¥53.31 Million ≈ $7.80 Million	CN¥7.11 Billion ≈ $1.04 Billion	-0.77pp
2017-12-31	1.52%	CN¥100.50 Million ≈ $14.71 Million	CN¥6.62 Billion ≈ $968.98 Million	+1.51pp
2016-12-31	0.01%	CN¥660.00K ≈ $96.58K	CN¥6.36 Billion ≈ $930.77 Million	-0.01pp
2015-12-31	0.02%	CN¥1.49 Million ≈ $218.62K	CN¥6.07 Billion ≈ $888.07 Million	-0.95pp
2013-12-31	0.97%	CN¥51.25 Million ≈ $7.50 Million	CN¥5.26 Billion ≈ $770.04 Million	+0.81pp
2005-12-31	0.16%	CN¥6.54 Million ≈ $957.01K	CN¥4.06 Billion ≈ $593.48 Million	-0.04pp
2004-12-31	0.20%	CN¥8.00 Million ≈ $1.17 Million	CN¥3.91 Billion ≈ $572.63 Million	-1.13pp
2003-12-31	1.34%	CN¥50.70 Million ≈ $7.42 Million	CN¥3.80 Billion ≈ $555.64 Million	+1.30pp
2002-12-31	0.04%	CN¥1.14 Million ≈ $166.38K	CN¥3.01 Billion ≈ $440.18 Million	+0.02pp
2001-12-31	0.02%	CN¥424.00K ≈ $62.04K	CN¥2.72 Billion ≈ $397.98 Million	-5.00pp
2000-12-31	5.02%	CN¥126.86 Million ≈ $18.56 Million	CN¥2.53 Billion ≈ $369.87 Million	--

pp = percentage points

About Tianjin Zhongxin Pharmaceutical Group Corp Ltd

SHG:600329 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.93 Billion

CN¥20.01 Billion CNY

Market Cap Rank

#5041 Global

#877 in China

Share Price

CN¥35.10

Change (1 day)

-0.28%

52-Week Range

CN¥34.04 - CN¥50.05

All Time High

CN¥54.12